Mimedx Group (MDXG) Equity Average: 2011-2025
Historic Equity Average for Mimedx Group (MDXG) over the last 13 years, with Sep 2025 value amounting to $227.8 million.
- Mimedx Group's Equity Average rose 30.52% to $227.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $227.8 million, marking a year-over-year increase of 30.52%. This contributed to the annual value of $167.9 million for FY2024, which is 169.24% up from last year.
- Per Mimedx Group's latest filing, its Equity Average stood at $227.8 million for Q3 2025, which was up 8.62% from $209.7 million recorded in Q2 2025.
- Mimedx Group's 5-year Equity Average high stood at $227.8 million for Q3 2025, and its period low was -$18.8 million during Q4 2022.
- Moreover, its 3-year median value for Equity Average was $161.9 million (2024), whereas its average is $121.9 million.
- Per our database at Business Quant, Mimedx Group's Equity Average crashed by 555.05% in 2022 and then surged by 3,179.11% in 2024.
- Quarterly analysis of 5 years shows Mimedx Group's Equity Average stood at -$2.9 million in 2021, then crashed by 555.05% to -$18.8 million in 2022, then soared by 484.04% to $72.0 million in 2023, then surged by 159.72% to $187.1 million in 2024, then soared by 30.52% to $227.8 million in 2025.
- Its Equity Average stands at $227.8 million for Q3 2025, versus $209.7 million for Q2 2025 and $197.9 million for Q1 2025.